StockNews.AI
GMED
StockNews.AI
95 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

1. Pomerantz LLP is investigating potential securities fraud by Globus Medical. 2. Globus missed Q1 2025 earnings and revenue estimates, indicating performance issues. 3. The company's stock plummeted 22.96% following the disappointing results. 4. Integration disruptions and weak deal closures affected the quarterly performance. 5. Investors are encouraged to join the class action for potential claims.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The substantial drop in stock price, along with missed estimates, indicates investor loss of confidence, similar to past downturns after poor earnings reports.

How important is it?

The article highlights significant performance issues and potential legal actions that directly affect GMED, meriting high importance.

Why Short Term?

Immediate impacts are expected due to investor reactions and ongoing investigations; however, recovery could occur with improved performance in future quarters.

Related Companies

SPTNBDX
Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE:GMED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Globus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about joining the class action]On May 8, 2025, Globus issued a press release reporting its financial results for the first quarter of 2025. Among other items, Globus reported non-GAAP earnings per share of $0.68, missing consensus estimates by $0.06, and revenue of $598.12 million, missing consensus estimates by $27.78 million and representing a 1.4% year-over-year decline. Globus's President and Chief Executive Officer said that the Company's "first quarter results were impacted by softer Enabling Technology deal closures, temporary integration related supply chain disruption, and timing of international distributor orders[.]"On this news, Globus's stock price fell $16.64 per share, or 22.96%, to close at $55.82 per share on May 9, 2025.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.Attorney advertising. Prior results do not guarantee similar outcomes.SOURCE: Pomerantz LLP

Related News